N‐of‐1 trials to facilitate evidence‐based deprescribing: Rationale and case study-Reference-Cited by-同舟云学术

N‐of‐1 trials to facilitate evidence‐based deprescribing: Rationale and case study

Published:2022-07-13 Issue:10 Volume:88 Page:4460-4473
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Goyal Parag¹²^ORCID,Safford Monika M.²,Hilmer Sarah N.³^ORCID,Steinman Michael A.⁴,Matlock Daniel D.⁵,Maurer Mathew S.⁶,Lachs Mark S.⁷,Kronish Ian M.⁸

Affiliation:

1. Division of Cardiology Weill Cornell Medicine New York NY United States

2. Division of General Internal Medicine Weill Cornell Medicine New York NY United States

3. Kolling Institute University of Sydney and Royal North Shore Hospital Sydney Australia

4. Division of Geriatrics University of California San Francisco San Francisco CA United States

5. Division of Geriatrics University of Colorado Denver CO United States

6. Department of Medicine Columbia University Irving Medical Center New York NY United States

7. Division of Geriatrics Weill Cornell Medicine New York NY United States

8. Center for Behavioral Cardiovascular Health Columbia University New York NY United States

Funder

National Institute on Aging

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15442

Reference132 articles.

1. Life Expectancy and Mortality Rates in the United States, 1959-2017

2. Prevalence of Multiple Chronic Conditions Among US Adults, 2018

3. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N‐of‐1 trials in epilepsy: A systematic review and lessons paving the way forward;Epilepsia;2024-09-10

2. Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to support a proactive approach;Expert Review of Clinical Pharmacology;2024-08-02

3. When cardiovascular medicines should be discontinued;European Heart Journal;2024-06-05

4. Using Patient Decision Aids for Cardiology Care in Diverse Populations;Current Cardiology Reports;2023-11

5. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper;European Geriatric Medicine;2023-10-09